1. CryoET reveals organelle phenotypes in huntington disease patient iPSC-derived and mouse primary neurons
- Author
-
Wu, Gong-Her, Smith-Geater, Charlene, Galaz-Montoya, Jesús G, Gu, Yingli, Gupte, Sanket R, Aviner, Ranen, Mitchell, Patrick G, Hsu, Joy, Miramontes, Ricardo, Wang, Keona Q, Geller, Nicolette R, Hou, Cathy, Danita, Cristina, Joubert, Lydia-Marie, Schmid, Michael F, Yeung, Serena, Frydman, Judith, Mobley, William, Wu, Chengbiao, Thompson, Leslie M, and Chiu, Wah
- Subjects
Brain Disorders ,Neurosciences ,Rare Diseases ,Stem Cell Research ,Orphan Drug ,Huntington's Disease ,Neurodegenerative ,Neurological ,Animals ,Mice ,Artificial Intelligence ,Disease Models ,Animal ,Huntingtin Protein ,Huntington Disease ,Induced Pluripotent Stem Cells ,Mitochondria ,Neurons ,Phenotype ,Proteomics ,Humans - Abstract
Huntington's disease (HD) is caused by an expanded CAG repeat in the huntingtin gene, yielding a Huntingtin protein with an expanded polyglutamine tract. While experiments with patient-derived induced pluripotent stem cells (iPSCs) can help understand disease, defining pathological biomarkers remains challenging. Here, we used cryogenic electron tomography to visualize neurites in HD patient iPSC-derived neurons with varying CAG repeats, and primary cortical neurons from BACHD, deltaN17-BACHD, and wild-type mice. In HD models, we discovered sheet aggregates in double membrane-bound organelles, and mitochondria with distorted cristae and enlarged granules, likely mitochondrial RNA granules. We used artificial intelligence to quantify mitochondrial granules, and proteomics experiments reveal differential protein content in isolated HD mitochondria. Knockdown of Protein Inhibitor of Activated STAT1 ameliorated aberrant phenotypes in iPSC- and BACHD neurons. We show that integrated ultrastructural and proteomic approaches may uncover early HD phenotypes to accelerate diagnostics and the development of targeted therapeutics for HD.
- Published
- 2023